A six-gene-based prognostic classifier consisting of DEPTOR, DPEP1, NAT8, PLOD2, SLC7A5, and SUSD2 was also created, with satisfactory performance in predicting the survival of patients with ccRCC. This evidence concerns the gene PLOD2 and nonpapillary renal cell carcinoma.